Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 8 min ago

AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors

Mon, 09/08/2014 - 12:51
WALTHAM, Mass., Sept. 8, 2014 -- (Healthcare Sales & Marketing Network) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced that John Fallon, M.D., senior vice president and chief physician executive at Blue Cross & Blue Shield of Massachusetts (BCBSMA), ...
Biopharmaceuticals, Personnel
AMAG Pharmaceuticals

Prospective Clinical Data On Web Aneurysm Embolization System Demonstrate Excellent Safety And High Rate Of Stable Occlusion In Difficult To Treat Aneurysms

Mon, 09/08/2014 - 12:48
ALISO VIEJO, Calif. and NICE, France, Sept. 8, 2014 -- (Healthcare Sales & Marketing Network) -- Sequent Medical, Inc. announced today the presentation of results from WEBCAST, a prospective study of the WEB™ Aneurysm Embolization System at the European S...
Devices, Interventional, Neurology
Sequent Medical, WEB Aneurysm, Embolization, MicroBraid

Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizumab Treatment in Asthma Patients with Eosinophilia

Mon, 09/08/2014 - 12:42
New Phase III data presented at European Respiratory Society Congress (ERS) builds on recent exacerbation reduction data, creating a special efficacy profile for reslizumab Reslizumab shown to significantly improve lung function and asthma control F...
Biopharmaceuticals
Teva Pharmaceutical, reslizumab, asthma, Eosinophilia

Cynosure Acquires Assets of RF Medical Device Manufacturer Ellman International, Inc.

Mon, 09/08/2014 - 12:37
Deal Complements Cynosure's Platform with Radiofrequency Energy Sources and Accessory Products for Aesthetic and Surgical Indications; Management to Discuss Transaction in Conference Call at 9:00 a.m. ET today WESTFORD, Mass., Sept. 8, 2014 -- (Healt...
Devices, Dermatology, Mergers & Acquisitions
Cynosure, Ellman International

Aurora Spine Appoints National Sales Manager in the UK

Fri, 09/05/2014 - 13:22
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Mike Coupland as National Sales Manager in the United Kingdom (UK). Mr. Coupland will manage Aurora's UK sales effo...
Devices, Orthopaedic, Neurosurgery, Personnel
Aurora Spine

KCI Partners with B. Braun Medical to Sell Prontosan(R) Wound Irrigation Solution for Use with V.A.C. VeraFlo(TM) Negative Pressure Wound Therapy

Fri, 09/05/2014 - 13:18
Combination demonstrated a reduction in OR visits, length of stay and time to final surgical closure in recently published study SAN ANTONIO--(Healthcare Sales & Marketing Network)--Kinetic Concepts, Inc. (KCI), an Acelity company, has established a new...
Devices, Wound Care, Distribution
Acelity, Kinetic Concepts, B. Braun Medical, Prontosan, V.A.C. VeraFlo

Mylan Launches Generic Boniva(R) Injection

Fri, 09/05/2014 - 12:43
PITTSBURGH, Sept. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Mylan Inc. (MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled glass syringes, which is the generic version...
Biopharmaceuticals, Generics, FDA, Product Launch
Mylan, Ibandronate, Boniva, Hoffmann-La Roche

OnCore Biopharma Closes Series R Financing

Fri, 09/05/2014 - 12:39
Funds to Expand OnCore's Portfolio of Oral Therapeutics for the Treatment of Chronic HBV OnCore to Advance HBV Compounds Into Phase 1 Clinical Development During 2015 Former Pharmasset Team Leveraging Expertise in Hepatitis R&D DOYLESTOWN, Pa., S...
Biopharmaceuticals, Venture Capital
OnCore Biopharma, hepatitis B

Aurora Spine Appoints Vice President of Sales

Thu, 09/04/2014 - 14:00
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Mike Wheelock as Vice President of Sales. Mr. Wheelock will be responsible for Aurora's United States sales efforts...
Devices, Orthopaedic, Neurosurgery, Personnel
Aurora Spine

Geneia Inks Multi-Year Partnership with Covidien to Enter $21 Billion Remote Patient Monitoring Market

Thu, 09/04/2014 - 13:55
ZephyrLIFE™ Technology from Covidien Powers Geneia's Remote Patient Monitoring Solution for the Home HARRISBURG, Pa. and CONCORD, N.H., Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Geneia® today announced a multi-year, strategic partn...
Devices, Monitoring
Geneia, Covidien, ZephyrLIFE

Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development

Thu, 09/04/2014 - 13:51
CORAL GABLES, Fla., Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Catalyst Pharmaceutical Partners, Inc. (CPRX), (Catalyst Pharmaceuticals), a biopharmaceutical company focused on developing and commercializing innovative therapies for people ...
Biopharmaceuticals, Personnel
Catalyst Pharmaceutical Partners

Chimerix Appoints W. Garrett Nichols, MD, MS as Chief Medical Officer

Thu, 09/04/2014 - 13:48
Essy Mozaffari, PharmD, MPH, MBA appointed Vice President, Market Access and Reimbursement Odin Naderer, PharmD, appointed Vice President, Clinical Pharmacology and Translational Medicine DURHAM, N.C., Sept. 4, 2014 -- (Healthcare Sales & Marketing N...
Biopharmaceuticals, Personnel
Chimerix

EndoCross Receives CE Mark Approval for the ENABLER-C Coronary Catheter System for the Crossing of Coronary Chronic Total Occlusions

Thu, 09/04/2014 - 13:45
YOKNEAM, Israel--(Healthcare Sales & Marketing Network)--EndoCross, Ltd., received CE Mark approval for the ENABLER-C Coronary Catheter System. The ENABLER-C features a unique controlled guidewire advancement technology currently available in the CE Marked...
Devices, INterventional Cardiology, Regulatory
EndoCross, ENABLER-C, Coronary Catheter, chronic total occlusions

Yale-New Haven Hospital Upgrades to Masimo SET(R) Pulse Oximetry for Improved Patient Outcomes

Thu, 09/04/2014 - 13:40
NEW HAVEN, CT and IRVINE, CA--(Healthcare Sales & Marketing Network) - Masimo (NASDAQ: MASI) today announced that Yale-New Haven Hospital -- a nonprofit, 1,541-bed tertiary medical center ranked among the best in the U.S. -- has upgraded system-wide to Ma...
Devices, Monitoring
Masimo, Masimo SET, pulse oximetry

Esaote Receives FDA Clearance for Its Compact MyLab Six Ultrasound System

Thu, 09/04/2014 - 13:35
Configurable applications and compact design combine in new affordable shared service ultrasound INDIANAPOLIS--(Healthcare Sales & Marketing Network)--Esaote North America announced that its new MyLab Six ultrasound system has received 510(k) clearance ...
Devices, FDA
Esaote North America, MyLab Six, ultrasound

Stereotaxis Receives FDA Clearance of Vdrive(TM) With V-Loop(TM) System

Thu, 09/04/2014 - 13:28
ST. LOUIS, Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS) announced today that it has received 510(k) clearance by the Food and Drug Administration (FDA) to market its Vdrive(TM) Robotic Navigation System with V-Loop(TM...
Devices, FDA
Stereotaxis, Vdrive, Robotic Navigation System

Johnson and Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid

Thu, 09/04/2014 - 13:22
NEW BRUNSWICK, N.J., Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (JNJ) today announced it will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate with its partne...
Biopharmaceuticals
Johnson & Johnson, Crucell, Janssen, Ebola, Filoviridae

BIND Therapeutics Appoints Two New Board Members

Wed, 09/03/2014 - 15:44
Industry leaders, Eric K. Rowinsky, M.D. and Amy W. Schulman, join BIND’s Board of Directors CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--BIND Therapeutics, Inc. (BIND), a clinical-stage nanomedicine platform company developing targeted and...
Biopharmaceuticals, Oncology, Personnel
BIND Therapeutics, Accurins, Medicinal Nanoengineering

Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board

Wed, 09/03/2014 - 15:42
EWING, N.J., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Celator Pharmaceuticals, Inc. (CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the appointment of Michael R. Dougherty as C...
Biopharmaceuticals, Oncology, Personnel
Celator Pharmaceuticals

MRI Interventions Welcomes Pascal E.R. Girin to Board of Directors

Wed, 09/03/2014 - 15:40
Newest Director Brings Additional Medical Device Management Experience, Executive Perspective to Board IRVINE, Calif., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- MRI Interventions, Inc. (MRIC) today announced that industry veteran Pascal...
Devices, Radiology, Surgery, Personnel
MRI Interventions, ClearPoint, intraoperative MRI

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong